FdaApplication
BLA 021172
Identifiers
- fda_app_no: BLA021172
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2001-11-01 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOVOLOG MIX 70/30 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | 700 UNITS/10ML;300 UNITS/10ML (70 UNITS/ML | Injectable Suspension |
| NOVOLOG MIX 70/30 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML | Injectable Suspension |
| NOVOLOG MIX 70/30 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML | Injectable Suspension |
| NOVOLOG MIX 70/30 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML | Injectable Suspension |
4 products